Skip to main navigation Skip to search Skip to main content

Enhanced resolution profiling in twins reveals differential methylation signatures of type 2 diabetes with links to its complications

  • Colette Christiansen*
  • , Louis Potier
  • , Tiphaine C. Martin
  • , Sergio Villicaña
  • , Juan E. Castillo-Fernandez
  • , Massimo Mangino
  • , Cristina Menni
  • , Pei Chien Tsai
  • , Purdey J. Campbell
  • , Shelby Mullin
  • , Juan R. Ordoñana
  • , Olga Monteagudo
  • , Perminder S. Sachdev
  • , Karen A. Mather
  • , Julian N. Trollor
  • , Kirsi H. Pietilainen
  • , Miina Ollikainen
  • , Christine Dalgård
  • , Kirsten Kyvik
  • , Kaare Christensen
  • Jenny van Dongen, Gonneke Willemsen, Dorret I. Boomsma, Patrik K.E. Magnusson, Nancy L. Pedersen, Scott G. Wilson, Elin Grundberg, Tim D. Spector, Jordana T. Bell*
*Corresponding author for this work

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Background: Type 2 diabetes (T2D) susceptibility is influenced by genetic and environmental factors. Previous findings suggest DNA methylation as a potential mechanism in T2D pathogenesis and progression. Methods: We profiled DNA methylation in 248 blood samples from participants of European ancestry from 7 twin cohorts using a methylation sequencing platform targeting regulatory genomic regions encompassing 2,048,698 CpG sites. Findings: We find and replicate 3 previously unreported T2D differentially methylated CpG positions (T2D-DMPs) at FDR 5% in RGL3, NGB and OTX2, and 20 signals at FDR 25%, of which 14 replicated. Integrating genetic variation and T2D-discordant monozygotic twin analyses, we identify both genetic-based and genetic-independent T2D-DMPs. The signals annotate to genes with established GWAS and EWAS links to T2D and its complications, including blood pressure (RGL3) and eye disease (OTX2). Interpretation: The results help to improve our understanding of T2D disease pathogenesis and progression and may provide biomarkers for its complications. Funding: Funding acknowledgements for each cohort can be found in the Supplementary Note.

Original languageEnglish
Article number105096
Pages (from-to)1-18
Number of pages18
JournalEbiomedicine
Volume103
Early online date3 Apr 2024
DOIs
Publication statusPublished - May 2024

Bibliographical note

Publisher Copyright:
© 2024 The Author(s)

Funding

Funding acknowledgements for each cohort can be found in the Supplementary Note. CC was supported by the National Institute for Health Research (NIHR) Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust and King’s College London and/or the NIHR Clinical Research Facility. This project also received support from the JPI ERA-HDHL DIMENSION project and UK Biological Sciences Research Council (BBSRC, BB/S020845/1 and BB/T019980/1 to JTB). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

FundersFunder number
NIHR Sheffield Clinical Research Facility
National Institute for Health and Care Research
Biological Sciences Research Council
Biotechnology and Biological Sciences Research CouncilBB/S020845/1, BB/T019980/1

    Keywords

    • DNA methylation
    • Genetics
    • Twins
    • Type 2 diabetes

    Fingerprint

    Dive into the research topics of 'Enhanced resolution profiling in twins reveals differential methylation signatures of type 2 diabetes with links to its complications'. Together they form a unique fingerprint.

    Cite this